ALLMedicine™ Headache Center

Dec 22nd, 2021 - In December 2020, the first COVID-19 vaccines received emergency use authorization in the United States.1,2 Billions of doses of vaccine have been administered worldwide.3 However, some individuals have concerns about receiving COVID-19 vaccinatio...

Jan 16th, 2022 - Fenestration of the cervical segment of the internal carotid artery is a very rare finding, and its origin is still not fully understood. Explanations of its genesis range from dissections leading to the fenestration to the more common interpretat...

Jan 15th, 2022 - Postdural puncture headache, a known complication of lumbar puncture, typically resolves with conservative management. Symptoms persist in a minority of patients, necessitating an epidural blood patch. One method of decreasing rates of postdural p...

Jan 15th, 2022 - COVID-19 is an acute respiratory infectious disease, which makes people difficult to breathe; in addition, it is often accompanied by headache, olfaction, and taste disorders of the neurological manifestations. Acupuncture has been proved to have ...

Jan 15th, 2022 - Klebsiella pneumoniae is once thought to be a less common cause of brain abscess in adults and is mainly hospital-acquired. Community-acquired CNS infection (brain abscess and meningitis) caused by K pneumoniae without other metastatic septic absc...

Dec 22nd, 2021 - In December 2020, the first COVID-19 vaccines received emergency use authorization in the United States.1,2 Billions of doses of vaccine have been administered worldwide.3 However, some individuals have concerns about receiving COVID-19 vaccinatio...

Jun 12th, 2021 - Editorial. Valuing headache's solution.|2021|Steiner TJ,Tinelli M,|diagnosis,prevention & control,diagnosis,prevention & control,diagnosis,prevention & control,diagnosis,prevention & control,diagnosis,prevention & control,diagnosis,prevention & co...

Feb 11th, 2021 - Side effects of the coronavirus disease 2019 (COVID-19) vaccines include pain at the injection site, fatigue, headache, myalgias, arthralgias, chills, and fever, all of which can be early indicators of an increased need for glucocorticoid replacem...

Jul 30th, 2020 - Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Contro...

May 7th, 2020 - Stroke is an uncommon but an important and under-recognized cause of morbidity and mortality in children. Strokes may be due to either brain ischemia or intracranial hemorrhage. Common symptoms of pediatric acute stroke include headache, vomiting,...

Dec 22nd, 2021 - In December 2020, the first COVID-19 vaccines received emergency use authorization in the United States.1,2 Billions of doses of vaccine have been administered worldwide.3 However, some individuals have concerns about receiving COVID-19 vaccinatio...

Jan 14th, 2022 - Conducting an initial, small, controlled clinical trial to assess for COVID-19 Antigen Presentation Therapeutic Biologics Mix activity that suggests the potential for clinical benefit of COVID-19 patients 20 Lower Than Mild COVID-19 Patients Posit...

Jan 14th, 2022 - Neuropathic pain following traumatic brachial plexus injuries is a common and debilitating problem that has been reported in up to 64-75% of patients. Neuropathic pain is difficult to treat, particularly when secondary to avulsion injuries of the ...

Jan 12th, 2022 - Primary Aim: Determine whether intranasal (IN) ketorolac is non-inferior to intravenous (IV) ketorolac for reducing pain in children with acute migraine headaches. We hypothesize that IN ketorolac is non-inferior to IV ketorolac in reducing acute ...

Jan 11th, 2022 - I. Specific Aims of Study: The ultimate aim of this Phase II open-label study is to test the research methods and approach necessary to successfully carry out a Phase III study for the treatment of post-traumatic headache (PTH). During this study,...

Dec 22nd, 2021 - In December 2020, the first COVID-19 vaccines received emergency use authorization in the United States.1,2 Billions of doses of vaccine have been administered worldwide.3 However, some individuals have concerns about receiving COVID-19 vaccinatio...

Jan 12th, 2022 - Ferrari et al 1provided information on an open label extension to the “LIBERTY” study which investigated the use of erenumab in subjects with episodic migraine that have failed multiple prior preventive medications. The initial Calcitonin gene-rel.

Jan 11th, 2022 - Key clinical point: The frequency of occipital bending (OB) was 2-fold higher in patients with migraine with visual aura than those without visual aura. Major finding: Overall, the prevalence of OB was 33.

Jan 10th, 2022 - The FDA has granted a fast track designation to enobosarm as a potential therapeutic option for patients with androgen receptor (AR)–positive, estrogen receptor (ER)–positive, HER2-negative, metastatic breast cancer who progressed on a nonsteroida...

Jan 10th, 2022 - It is difficult to know where exactly to begin this commentary regarding the FDA approval to permit commer-cial sales of the Alzheimer disease drug aducanumab-avwa (Aduhelm). There are so many disturbing features of this story, with likely more to...